Functionally Different HA-1 Specific T Cells Use the Same TRBV7-9: A Snake in the Grass for T Cell Receptor Transfer Studies
暂无分享,去创建一个
W. Burlingham | E. Schrama | J. Pool | E. Blokland | Dierselhuis | Goulmy
[1] N. Kröger,et al. Peptide Length Extension Skews the Minor HA-1 Antigen Presentation toward Activated Dendritic Cells but Reduces Its Presentation Efficiency , 2010, The Journal of Immunology.
[2] M. V. van Loenen,et al. Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies , 2009, Haematologica.
[3] W. Burlingham,et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. , 2009, Blood.
[4] J. Falkenburg,et al. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice , 2006, Leukemia.
[5] L. Hambach,et al. Immunotherapy of cancer through targeting of minor histocompatibility antigens. , 2005, Current opinion in immunology.
[6] T. Mutis,et al. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. , 2004, Blood.
[7] Junchao Cai,et al. Minor H Antigen HA-1–specific Regulator and Effector CD8+ T Cells, and HA-1 Microchimerism, in Allograft Tolerance , 2004, The Journal of experimental medicine.
[8] Els Goulmy,et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Wilke,et al. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping. , 2002, The hematology journal : the official journal of the European Haematology Association.
[10] P. Moss,et al. Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease , 1999, Nature Medicine.
[11] R. Verdijk,et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. , 1999, Blood.
[12] J. Shabanowitz,et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. , 1998, Science.
[13] P. J. van den Elsen,et al. Interindividual conservation of T-cell receptor beta chain variable regions by minor histocompatibility antigen-specific HLA-A*0201-restricted cytotoxic T-cell clones. , 1995, Blood.
[14] A. Bakker,et al. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. , 1992, Journal of immunology.
[15] R. Brand,et al. Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients , 2010, Leukemia.
[16] M. Heemskerk,et al. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer. , 2005, Haematologica.
[17] P. Moss,et al. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand. , 2000, The hematology journal : the official journal of the European Haematology Association.